Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 223Pancreatic Neoplasms 140Stomach Neoplasms 87Carcinoma, Hepatocellular 82Carcinoma, Non-Small-Cell Lung 64Esophageal Neoplasms 63Colonic Neoplasms 60Breast Neoplasms 52Rectal Neoplasms 50Ovarian Neoplasms 46Neoplasm Metastasis 41Lung Neoplasms 41Cholangiocarcinoma 41Neoplasms 39Prostatic Neoplasms 33Melanoma 33Liver Neoplasms 33Gastrointestinal Neoplasms 33Sarcoma 27Endometrial Neoplasms 27Carcinoma, Renal Cell 24Squamous Cell Carcinoma of Head and Neck 23Biliary Tract Neoplasms 23Urinary Bladder Neoplasms 21Uterine Cervical Neoplasms 19Esophageal Squamous Cell Carcinoma 19Head and Neck Neoplasms 16Adenocarcinoma Of Esophagus 16Small Cell Lung Carcinoma 15Gastrointestinal Stromal Tumors 15

Interventions

irinotecan sucrosofate 1Folfox protocol 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Rectal Cancer × Gastrointestinal × 30 days × Clear all
NCT03781323 2026-06-04

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

University of Rochester

Phase 2 Active not recruiting
12 enrolled 9 charts
Gastrointestinal

Advanced Rectal Cancer

NCT07281157 2026-06-03

Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡